GPC Biotech's Acquisition

GPC Biotech was acquired by Agennix on March 06, 2000.

GPC Biotech AG is a publicly traded biopharmaceutical company focused on anticancer drugs. GPC Biotech's lead product candidate is satraplatin, an oral platinum compound. The Company has various …

Articles about GPC Biotech's Acquisition: